CADX Dividend History & Description — Cadence Pharmaceuticals Inc
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. As of Dec 31 2012, Co. had rights to one product, OFIRMEV® (acetaminophen) injection, an intravenous formulation of acetaminophen. The U.S. Food and Drug Administration has approved OFIRMEV, which is used for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever in adults and children two years of age and older. When considering the Cadence Pharmaceuticals Inc stock dividend history, we have taken known splits into account, such that the CADX dividend history is presented on a split-adjusted ("apples to apples") basis. Cadence Pharmaceuticals Inc dividend history is presented both in graphical/chart form, and as a CADX dividend history data table along the right-hand column.